Telehealth weight management · Provider sources reviewed

Polly: weight-loss provider profile

Polly advertises compounded semaglutide and tirzepatide with independent clinicians and partner pharmacies. Its no-membership message still requires a separate check of subscription and pharmacy-submission terms.

Sources checked October 15, 2026 · Public-source research · AI-assisted · Medical review pending

Polly, formerly presented as Piper, is a service platform operated by Piper Wellness LLC doing business as JoinPolly. Its public site connects an online intake with an independent clinician and, if prescribed, a partner pharmacy. This review follows the company’s public offer and policies checked October 15, 2026; it is not a patient account or a test of the service.

The useful distinction is between an advertised simple price and the agreement attached to a particular order. We could verify the medication menu, named example pharmacies and cancellation rules, but the accessible homepage did not show a numeric treatment price. A personalized quote is still needed before comparing Polly with a priced monthly plan.

Current findings for Polly

Polly GLP-1 public offer and cancellation diagram
Editorial diagram of public-source findings, checked October 15, 2026.

What the public offer establishes

The homepage labels both semaglutide and tirzepatide as compounded injections. It advertises the same price across doses, no membership fee, provider support and free next-day-air shipping. These are company representations, not independently measured care or delivery performance. The numeric price, supply period, required lab charges and any first-payment offer were not established by the page we reviewed.

Polly describes self-pay care without insurance billing. HSA or FSA reimbursement depends on the individual plan. The advertised nationwide network does not establish that a particular medication, pharmacy or clinician is available for every person in every state; confirm the selected service during the clinical eligibility review.

Identify the practice and the dispensing pharmacy

The company distinguishes its platform from the independent professionals who provide medical care. Its FAQ names Hallandale Pharmacy and VialsRx as examples within a 503A compounding network. A network example is not confirmation of the pharmacy assigned to your prescription or an independent license inspection. Ask for the prescriber, practice, dispensing address and state-board details before the order is sent.

The intake is reviewed for clinical suitability; it does not guarantee a prescription. Follow-up is described through a patient portal, but we did not establish a guaranteed clinician-response time or urgent-care arrangement. The website’s additional wellness products do not establish that those products are necessary for a weight-management prescription.

No membership fee can still mean automatic renewal

The terms say certain products and services require automatically renewing subscriptions, with the interval described at checkout. Obtain the selected plan’s billing schedule rather than reading the no-membership message as a promise of no future charges. The terms also distinguish pharmacy-network fulfillment from a prescription sent elsewhere, where the patient pays that outside pharmacy directly.

The refund policy says plan cancellation takes effect after confirmation, with the current billing cycle remaining active and future renewals stopped. It does not promise prorated refunds for unused time. For a six-month plan with at least three months remaining, a refund request is discretionary rather than automatic. The reviewed policy does not state a universal advance-notice cutoff for every renewal.

The important refund boundary comes before shipment

Under the April 29, 2026 policy, a cancellation after a consultation can qualify for a refund if the medication order has not yet been submitted to the pharmacy. Once the prescription is transmitted, the policy says cancellation and refund are unavailable for that order. Waiting for a shipping notification can therefore miss the stated cutoff. Medical ineligibility determined by the clinician is described as eligible for a full refund.

The policy directs customers to its listed care contact or portal for refund requests and requires prompt documentation for delivery problems. Damaged or missing-delivery reports have a 24-hour notice window; promised review and repayment periods are company timelines, not results we tested. Billing-error refunds and discretionary service complaints have separate conditions. Read the full policy alongside the terms, which it says control in a conflict.

Evidence limits that matter for the decision

Compounded preparations are not FDA-approved. Named pharmacies, consistent-dose pricing and an overnight-shipping claim do not establish clinical equivalence to an approved product or superiority over another service. This review assigns no clinical score and does not verify outcomes from promotional images or testimonials.

Before committing, keep a copy of the offer, final charge, supply description and cancellation confirmation. For a delivery that appears warm or mishandled, ask the dispensing pharmacist for medication-specific instructions and follow FDA’s warning against using an injectable GLP-1 medicine that arrives warm or inadequately refrigerated. A retailer’s refund position does not determine whether a medicine is suitable to use.

Understand the medication before comparing providers

Approved weight-management options include Wegovy (semaglutide), Zepbound (tirzepatide) and Foundayo (orforglipron), each with its own indication, formulation and instructions. Ozempic and Mounjaro are diabetes brands. The current provider findings above identify what could be verified about this company; this general comparison does not establish that it offers every named medicine.

Wegovy has injectable and oral formulations, Zepbound is injectable, and Foundayo is oral. A compounded or dissolvable product is not the approved branded product. Identify the exact prescription and route before comparing price or applying a trial result.

Compounded medicines are not FDA-approved. FDA recommends them only when a patient’s medical needs cannot be met by an approved medicine. Its April 2026 update says semaglutide and tirzepatide are not on the drug shortage list or the 503B bulks list. Patient-specific exceptions and other legal conditions matter; a “personalized” label, vitamin additive, or pharmacy registration does not by itself establish compliance or effectiveness.

Safety questions for the prescribing clinician

The approved products cited here have a boxed warning about thyroid C-cell tumors in rodents; whether they cause these tumors in humans is unknown. Their contraindications include a personal or family history of medullary thyroid carcinoma (MTC), MEN 2, and specified serious allergic reactions. These are specific conditions, rather than a statement that every thyroid disorder rules out treatment. Review the exact product label with your clinician.

Tell the clinician about severe stomach-emptying problems, pancreatitis or gallbladder history, kidney concerns, diabetic eye disease, and every medicine or supplement you use. The labels do not recommend these products in severe gastroparesis. Insulin and medicines such as sulfonylureas can increase low-blood-sugar risk when used with them; adjustments belong with the prescriber. These examples do not replace the full safety review.

For weight management, Wegovy should be discontinued when pregnancy is recognized, and its label calls for stopping at least two months before a planned pregnancy. Ozempic also specifies at least two months before a planned pregnancy. Discuss the plan before trying to conceive. Wegovy tablets are not recommended during breastfeeding; the injection requires its own benefit-and-risk discussion.

Zepbound should be discontinued when pregnancy is recognized. Tirzepatide can reduce the effectiveness of oral hormonal contraceptives: the Zepbound and Mounjaro labels advise a non-oral method or an added barrier method for four weeks after starting and for four weeks after each dose increase. Ask the clinician about pregnancy planning and breastfeeding for the exact prescription.

Foundayo also calls for discontinuation when pregnancy is recognized. Its oral-contraceptive precautions use 30 days after starting and 30 days after each dose increase. It is not recommended for nursing women. Do not substitute one product’s contraception or pregnancy instructions for another’s.

Severe abdominal pain that does not go away, with or without vomiting, can be a pancreatitis warning; the labels instruct patients to stop the medicine and seek medical help promptly. Repeated vomiting or inability to keep fluids down also needs prompt assessment. For trouble breathing or swallowing, swelling of the face, tongue or throat, or collapse suggesting a serious allergic reaction, call 911 or your local emergency number immediately. Your provider should explain urgent and after-hours care before treatment starts.

Tell the anesthesia or procedure team about treatment before surgery or deep sedation. Do not independently combine GLP-1 products, shorten injection intervals or restart an old high dose after a break. Procedure planning and side effects and warning symptoms explain the questions to resolve with the care team.

Questions to resolve before paying Polly

  • What exact amount is due today, what supply period does it buy, and when does the selected plan renew?
  • Which independent practice and prescriber will handle my case in my state?
  • Which pharmacy will dispense this prescription, and when is the order transmitted there?
  • Does the written quote include required labs, supplies and all follow-up services?
  • How will you confirm cancellation before the next charge, and what happens to an already submitted order?

Ask for a written quote showing the medication, care or membership fee, labs, shipping, supplies, first payment, renewal payment, and cancellation cutoff. A monthly equivalent on a prepaid plan is different from paying that amount every month. A four-week supply and a calendar-month subscription also have different annual totals.

Verify your prescriber’s license and the dispensing pharmacy with the relevant state boards. Check that the pharmacy named on your prescription matches the pharmacy on the package. If injectable medication arrives warm or inadequately refrigerated, FDA advises against using it; contact the dispensing pharmacy for instructions. Avoid products sold as research chemicals or without a prescription.

How to use this profile

This is a review of public information, not a hands-on clinical test or a verified patient review. We do not assign star ratings to clinical care, medication quality, response time, or shipping. An advertised benefit remains a provider claim unless independent evidence supports the specific claim. Confirm current availability, state eligibility, and the final terms directly before enrolling.

Read our source and correction policy and commercial disclosure. Medical review has not been completed.

Sources and verification

Provider pages document what a company advertises. Prescribing information and regulator guidance support medical and regulatory claims. Reviewing a website does not verify its clinical service, pharmacy quality, or your eligibility.

  1. Polly: current medication menu and care FAQ
    provider · Text reviewed · Checked October 15, 2026
  2. Polly: subscription and platform terms
    provider · Text reviewed · Checked October 15, 2026
  3. Polly: refund and cancellation policy
    provider · Text reviewed · Checked October 15, 2026
  4. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss | FDA
    regulator · Text reviewed · Checked October 2, 2026
  5. Wegovy prescribing information
    prescribing information · Text reviewed · Checked October 4, 2026
  6. Ozempic prescribing information
    prescribing information · Text reviewed · Checked October 4, 2026
  7. Zepbound prescribing information
    prescribing information · Text reviewed · Checked October 4, 2026
  8. Mounjaro prescribing information
    prescribing information · Text reviewed · Checked October 4, 2026
  9. Foundayo prescribing information
    prescribing information · Text reviewed · Checked October 4, 2026
  10. Anaphylaxis: MedlinePlus Medical Encyclopedia
    clinical guidance · Text reviewed · Checked October 2, 2026
  11. FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize | FDA
    regulator · Text reviewed · Checked October 4, 2026